Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?

Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists* / adverse effects
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Male
  • Pandemics*
  • Pneumonia, Viral*
  • Prostatic Neoplasms* / drug therapy
  • SARS-CoV-2

Substances

  • Androgen Antagonists